Smartlab Europe

Press Releases

Oncodesign and OSEO, winners of the IMODI project from the French Government’s Investing for the Future program, announce funding of EUR 13.4 million

In the presence of French president, Francois Hollande, Francois Drouin, OSEO's CEO and vice-president of the BPI (Banque Publique d'Investissement), announced to Philippe Genne, Oncodesign's CEO and leader of the IMODI (Innovative MODels Initiative), that this project will...

Quintiles Digital Properties Win Two Web Marketing Association Awards

Quintiles has received further recognition for the company’s market-leading digital communications with two “Internet Advertising Competition” (IAC) awards: one for its corporate website Quintiles.com and one for its patient education site ClinicalResearch.com. The IAC...

Eyevensys appoints Dr Ivan Cohen-Tanugi as CEO

Eyevensys, a company developing a new non-viral gene therapy process to treat ocular illnesses that enables prolonged production of all therapeutic proteins through electrotransfer, today announces the appointment of Dr Ivan Cohen-Tanugi as CEO.  ...

Med Opportunity Partners, LLC Makes Strategic Investment in Pfanstiehl, Inc.

Med Opportunity Partners LLC (“MEDOP”) a Greenwich CT-based private equity firm focused exclusively on the health care sector announced today its acquisition of Ferro Pfanstiehl Laboratories Inc. a global leader in cGMP carbohydrates and Active Pharmaceutical Ingredients (APIs)...

Innovatix to Exhibit at Inaugural National Association of Specialty Pharmacy Conference

Innovatix LLC the nation’s leading non-acute care group purchasing organization (GPO) will be exhibiting at the inaugural National Association of Specialty Pharmacy (NASP) Conference next week April 2-3 at the Manchester Grand Hyatt in San Diego. ...

Oncodesign signs a partnership agreement and an option for exclusive licensing with Sanofi in the area of tissue protection and repair

Oncodesign, a company specializing in drug discovery and providing pharmacological evaluation services in the field of oncology, today announces that it has signed a second research collaboration agreement with Sanofi.  This partnership follows a...

GLOBAL BIOENERGIES receives 740,000 euros from OSEO to create a pre-industrial strain

Global Bioenergies the industrial biology company that develops sustainable routes to light olefins announces a new 740000 euros financing from OSEO a French SME-funding state agency to support the creation of an isobutene production strain compatible with industrial...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »